Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | Director | September 15, 2021 | September 17, 2021 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,583 |
Ending reported balance
After 2021-09-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-09-15 · Exercise / conversion · Acquired 4,000 · Balance 21,583 Row 2 · 2021-09-15 · Sale · Disposed 4,000 · Balance 17,583 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.54 · Expires 2022-05-15 | Direct | 11,806 |
Reported balance
After 2021-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-15 · Exercise / conversion · Disposed 4,000 · Balance 11,806 F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,841 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,521 · Balance 62,841 F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTRICON CORP
Report date May 24, 2022 · Filed May 25, 2022
Section 16 reporting ended · disclosed 2022-05-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-24 transaction · row 1
1 source rowRow 1 · 2022-05-24 · Disposition to issuer · Disposed 11,154 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · derivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,200 Underlying: Common Stock · 3,400 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 6,200 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · derivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,600 Underlying: Common Stock · 6,200 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · derivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,556 Underlying: Common Stock · 3,400 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · derivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,037 Underlying: Common Stock · 1,000 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 180 | $94.59 | $17,026.27 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F4 · price: Represents the weighted average share price of an aggregate total of 180 shares sold in the price range of $94.590 to $94.655 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 7,520 | $93.44 | $702,643.23 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,988 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 7,520 shares sold in the price range of $93.12 to $94.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,300 | $92.34 | $581,756.49 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,508 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 6,300 shares sold in the price range of $92.12 to $93.11 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,400 | $44.19 | $150,246.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 6,200 | $38.54 | $238,948.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,400 | $16.62 | $56,508.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 23:43 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $8.37 | $8,370.00 |
DisclosureSEC source: 0001209191-17-045602 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · derivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,600 Underlying: Common Stock · 3,400 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 6,200 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · derivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,800 Underlying: Common Stock · 6,200 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,700 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · derivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,956 Underlying: Common Stock · 4,700 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · derivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,037 Underlying: Common Stock · 1,000 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. F5 · derivative.expiration_date: Previous Forms 4 and 3 indicated an incorrect expiration date. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 9,400 | $91.10 | $856,296.76 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F3 · price: Represents the weighted average share price of an aggregate total of 9,400 shares sold in the price range of $90.89 to $91.44 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,900 | $90.53 | $534,124.64 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,208 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 5,900 shares sold in the price range of $89.8801 to $90.8700 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,400 | $44.19 | $150,246.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 6,200 | $38.54 | $238,948.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,700 | $16.62 | $78,114.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 21:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $8.37 | $8,370.00 |
DisclosureSEC source: 0001209191-17-040899 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2017 Filed May 12, 2017 17:35 UTC | Inogen Inc INGN · Entity 2083 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $83.30 | $0.00 |
DisclosureSEC source: 0001209191-17-031808 · doc4.xml · derivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-05-10 F1 · derivative.exercise_date: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but will vest fully on the date of the next Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is May 11, 2017. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 5,680 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-17-004654 · doc4.xml · derivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,656 Underlying: Common Stock · 5,680 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. F4 · derivative.expiration_date: Previous Forms 4 indicated an incorrect expiration date. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3 | $64.96 | $194.88 |
DisclosureSEC source: 0001209191-17-004654 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,677 | $63.96 | $363,120.79 |
DisclosureSEC source: 0001209191-17-004654 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,811 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 5,677 shares sold in the price range of $63.57 to $64.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 00:05 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,680 | $16.62 | $94,401.60 |
DisclosureSEC source: 0001209191-17-004654 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:36 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-16-155852 · doc4.xml · derivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,336 Underlying: Common Stock · 8,000 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. F5 · derivative.expiration_date: Previous Forms 4 indicated an incorrect expiration date. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:36 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 600 | $66.18 | $39,710.52 |
DisclosureSEC source: 0001209191-16-155852 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $66.155 to $66.190 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:36 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 7,400 | $65.54 | $485,002.66 |
DisclosureSEC source: 0001209191-16-155852 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,408 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 7,400 shares sold in the price range of $65.08 to $66.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 20:36 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 8,000 | $16.62 | $132,960.00 |
DisclosureSEC source: 0001209191-16-155852 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 01:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-16-151052 · doc4.xml · derivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,336 Underlying: Common Stock · 8,000 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. F5 · derivative.expiration_date: Previous Forms 4 indicated an incorrect expiration date. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 01:46 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,600 | $64.20 | $423,711.42 |
DisclosureSEC source: 0001209191-16-151052 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 6,600 shares sold in the price range of $63.84 to $64.43 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 01:46 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,400 | $63.29 | $88,605.02 |
DisclosureSEC source: 0001209191-16-151052 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,408 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 1,400 shares sold in the price range of $62.81 to $63.72 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2016 Filed Nov 18, 2016 01:46 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 8,000 | $16.62 | $132,960.00 |
DisclosureSEC source: 0001209191-16-151052 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 20:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-16-146366 · doc4.xml · derivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,037 Underlying: Common Stock · 5,555 shares Expires 2023-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 20:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,534 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-16-146366 · doc4.xml · derivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,534 shares Expires 2022-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012. F5 · derivative.expiration_date: The Form 3 filed on February 12, 2014 mistakenly reported the expiration date as 03/28/2012. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 20:42 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,555 | $56.22 | $312,307.10 |
DisclosureSEC source: 0001209191-16-146366 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F3 · price: Represents the weighted average share price of an aggregate total of 5,555 shares sold in the price range of $55.770 to $56.525 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 20:42 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,534 | $56.32 | $86,401.48 |
DisclosureSEC source: 0001209191-16-146366 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,363 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016. F2 · price: Represents the weighted average share price of an aggregate total of 1,534 shares sold in the price range of $56.15 to $56.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 20:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 5,555 | $8.37 | $46,495.35 |
DisclosureSEC source: 0001209191-16-146366 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 20:42 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,534 | $0.81 | $1,242.54 |
DisclosureSEC source: 0001209191-16-146366 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.